MTOR and ulcer disease: In the current ulcerative colitis model, the increased expression of mTOR and IL-6 in the colon of ulcerative rats enhanced the generation of Th17 cells and the release of IL-17 and IL-23 in line with reducing the expression of IL-10, the anti-inflammatory cytokine.